Literature DB >> 19946227

Deleterious effects of nicotine on the ultrastructure of oocytes: role of gamma-tocotrienol.

Mohd Hamim Rajikin1, Elda Surhaida Latif, Megat Radzi Mar, A Gapor Mat Top, Norfilza M Mokhtar.   

Abstract

BACKGROUND: Previous studies have shown that nicotine enhances oxidative DNA damage and leads to increased lipid peroxidation, which affects embryo development. The present study investigated the effect of daily supplementation of gamma-tocotrienol on oocytes of nicotine-treated mice. MATERIAL/
METHODS: Immature female mice (18-25 g) were divided into three groups. For 30 days, group A (control group) received saline (0.2 ml/day s.c.), group B nicotine (5 mg/kg/day s.c. in saline), and group C nicotine with gamma-tocotrienol (60 mg/kg/day p.o.). The animals were superovulated following these schedules.
RESULTS: Scanning electron microscopy (SEM) showed that the nicotine-treated oocytes appeared nonspherical with rough surface and the zona pellucida (zp) was torn and became irregular. Supplementation with gamma-tocotrienol in the nicotine-treated mice retained the spherical shape of the oocytes with intact zp; however, the surfaces of the oocytes remained irregular and rough. Transmission electron microscopy (TEM) following chronic nicotine treatment showed loosening of the boundary and tearing of the zp. The perivitelline space was also widened. The cytoplasm of the oocytes retained abundant rough endoplasmic reticulum (rER) with numerous vesicles. Mitochondria were highly dense, with no cristae. The administration of gamma-tocotrienol partially reduced the detrimental effects of nicotine by retaining the smooth boundary of the zp with the tight perivitelline space. There was less rER with no visible vesicle and a lower amount of dense mitochondrial matrix.
CONCLUSIONS: This study documented that chronic nicotine treatment adversely affects the ultrastructure of oocytes, while gamma-tocotrienol treatment at least minimizes the nicotine-induced damage to oocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946227

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

1.  Anxiety, depression and methods of stress coping in patients with nicotine dependence syndrome.

Authors:  Tadeusz Pietras; Andrzej Witusik; Michał Panek; Janusz Szemraj; Paweł Górski
Journal:  Med Sci Monit       Date:  2011-05

2.  Annatto (Bixa orellana) δ-TCT Supplementation Protection against Embryonic Malformations through Alterations in PI3K/Akt-Cyclin D1 Pathway.

Authors:  Siti Syairah Mohd Mutalip; Mohd Hamim Rajikin; Sharaniza Ab Rahim; Norashikin Mohamed Noor Khan
Journal:  Biomolecules       Date:  2019-01-10

3.  Nicotine-induced cessation of embryonic development is reversed by γ-tocotrienol in mice.

Authors:  Yuhaniza Shafinie Kamsani; Mohd Hamim Rajikin; Nor-Ashikin Mohamed Nor Khan; Nuraliza Abdul Satar; Amar Chatterjee
Journal:  Med Sci Monit Basic Res       Date:  2013-03-06

4.  Effect of vitamin e on oocytes apoptosis in nicotine-treated mice.

Authors:  Ebrahim Asadi; Mehrdad Jahanshahi; Mohammad Jafar Golalipour
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

5.  Effects of Nicotine and Tocotrienol-Rich Fraction Supplementation on Cytoskeletal Structures of Murine Pre-Implantation Embryos.

Authors:  Nurul Kamsani Hamirah; Yuhaniza Shafinie Kamsani; Nor-Ashikin Mohamed Nor Khan; Sharaniza Ab Rahim; Mohd Hamim Rajikin
Journal:  Med Sci Monit Basic Res       Date:  2017-12-08

Review 6.  Vitamin E as an Antioxidant in Female Reproductive Health.

Authors:  Siti Syairah Mohd Mutalip; Sharaniza Ab-Rahim; Mohd Hamim Rajikin
Journal:  Antioxidants (Basel)       Date:  2018-01-26

7.  Epistatic evidence for gender-dependant slow neurotransmission signalling in substance use disorders: PPP1R12B versus PPP1R1B.

Authors:  Kefu Liu; Juan Zhao; Chunnuan Chen; Jie Xu; Richard L Bell; Frank S Hall; George F Koob; Nora D Volkow; Hong Qing; Zhicheng Lin
Journal:  EBioMedicine       Date:  2020-10-21       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.